Tanvex BioPharma (TPE:6541) FCF Yield %: -15.27 (As of Jul. 05, 2026)


TPE:6541 Tanvex BioPharma Inc TPE:6541
57 GF Score
Price NT$41.40
GF Value NT$254.61
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Tanvex BioPharma FCF Yield %?

Tanvex BioPharma TPE:6541 +2.10% 57 FCF Yield % is -15.27 as of Jul. 05, 2026. GuruFocus rates TPE:6541 with a GF Score™ of 57/100 and a GF Value™ of NT$254.61 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,409 Biotechnology companies, Tanvex BioPharma ranks worse than 61.82% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Tanvex BioPharma's Trailing 12-Month Free Cash Flow is NT$-1,675.6 Mil, and Market Cap is NT$10,970.4 Mil. Therefore, Tanvex BioPharma's FCF Yield % for today is -15.27%.

The historical rank and industry rank for Tanvex BioPharma's FCF Yield % or its related term are showing as below:

TPE:6541' s FCF Yield % Range Over the Past 10 Years
Min: -29.78   Med: -11.75   Max: -5.4
Current: -15.27


During the past 13 years, the highest FCF Yield % of Tanvex BioPharma was -5.40%. The lowest was -29.78%. And the median was -11.75%.

TPE:6541's FCF Yield % is ranked worse than
61.82% of 1409 companies
in the Biotechnology industry
Industry Median: -9.25 vs TPE:6541: -15.27

Tanvex BioPharma's FCF Margin % for the quarter that ended in Dec. 2025 was -353.76%.


Tanvex BioPharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Tanvex BioPharma FCF Yield % Related Terms


Tanvex BioPharma FCF Yield % Historical Data

* Premium members only.

The historical data trend for Tanvex BioPharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tanvex BioPharma FCF Yield % Chart

Tanvex BioPharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.92 -11.55 -17.28 -11.79 -11.50

Tanvex BioPharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.84 -7.91 -12.70 -10.15 -17.38

TPE:6541 vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Tanvex BioPharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tanvex BioPharma FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tanvex BioPharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Tanvex BioPharma's FCF Yield % falls into.


TPE:6541
57GF Score
Tanvex BioPharma Inc TPE:6541
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tanvex BioPharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Tanvex BioPharma's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1675.641 / 14567.465
=-11.50%

Tanvex BioPharma's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-633.056 * 4 / 14567.465
=-17.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -15.27 mean?
Tanvex BioPharma (TPE:6541) has a FCF Yield % of -15.27 as of Jul. 05, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tanvex BioPharma and its competitors. According to the industry distribution chart, Tanvex BioPharma ranks #871 out of 1409 companies in the Biotechnology industry, placing it in the top 61.8%.
Is Tanvex BioPharma's FCF Yield % too high?
Tanvex BioPharma's current FCF Yield % is -15.27. Based on the distribution chart, Tanvex BioPharma ranks #871 out of 1409 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Tanvex BioPharma has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tanvex BioPharma's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Tanvex BioPharma ranks #871 out of 1409 companies for FCF Yield %. This places Tanvex BioPharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tanvex BioPharma and its competitors. Tanvex BioPharma's current FCF Yield % is -15.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tanvex BioPharma stock overvalued right now?
Based on GuruFocus' analysis, Tanvex BioPharma (TPE:6541) is currently considered Possible Value Trap. The stock's GF Value™ is NT$254.61, compared to a current price of NT$41.40 — trading 83.7% below its estimated fair value. The current FCF Yield % is -15.27. Tanvex BioPharma's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Tanvex BioPharma (TPE:6541), the current FCF Yield % is -15.27 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tanvex BioPharma (TPE:6541) Overvalued in 2026?

Based on GuruFocus' analysis, Tanvex BioPharma stock appears to be undervalued. The current stock price of NT$41.40 is trading 83.7% below its estimated GF Value™ of NT$254.61. GuruFocus considers Tanvex BioPharma to be Possible Value Trap.

Key valuation signals for TPE:6541:

  • FCF Yield %: -15.27
  • GF Value™: NT$254.61 vs. price of NT$41.40 (83.7% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the TPE:6541 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tanvex BioPharma Business Description

Address No. 12-2, Shengyi Road, Section 2, 6th Floor, Hsinchu County, Zhubei, TWN, 106
Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products and contract development and manufacturing of biological medicine. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others. Geographically, the company operates in Asia, America, Europe, and Australia. The company generates a majority of its revenue from the USA.
57GF Score

Get the complete analysis for TPE:6541

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$41.40
Price
NT$254.61
GF Value